«You really can't know what will have
more immunogenicity until they get into trials, and that's why we are testing them,» Fauci adds.
Not exact matches
The development process often takes 15 to 20 years or
more and requires virus cultivation, animal model testing, product formulation,
immunogenicity testing and years of costly clinical trials.
Such models are valuable for the analysis of parameters associated with vaccine safety,
immunogenicity, delivery and protection as NHPs replicate key features of the human immune response
more faithfully than any other animal model.
Researchers seek to sustain or increase this effect, and these clinical trials will enable them to collect
more data and samples for
immunogenicity studies.